Biohope — Unstaged equity

The National Kidney Foundation Innovation Fund made an undisclosed strategic investment in Biohope. The money funds clinical validation studies and the push for US regulatory approval of Immunobiogram® for kidney transplant patients. The release gives no stage; Tracxn files it as a Seed round.

LeadNational Kidney Foundation Innovation Fund RoundUnstaged equity Announced14 May 2026 CityMadrid SectorHealthtech & Bio · Healthtech / In vitro diagnostics Source B

Something wrong? Suggest a correction →